Organise a dual-use research review: evidence, reviewers, justified decisions, escalation (PAID $1.50)

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations declare a non-read-only, open-world, non-idempotent write, and the description is consistent with that but adds no behavioral detail: no mention of what the 'action' parameter can be, whether prior reviews must exist, whether escalation is a separate phase, or what side effects occur. For a 20-parameter multi-operation tool with zero annotation nuance, this is a major gap.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

It is short and front-loaded, but the first sentence is a verbatim restatement of the title, so half the text is duplicated metadata. The route/price line is the only unique content, and it is a single efficient sentence.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

An output schema exists, so return values need not be explained, but with 20 undocumented parameters, no action enumeration, and no description of the review lifecycle (evidence -> reviewers -> decision -> escalation), an agent cannot reliably assemble a correct call. The description is far too thin for the tool's complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0% across 20 parameters, so the description must carry the burden, yet it only implicitly gestures at a handful of fields (evidence, reviewer, decision, escalate_to). Critical fields like action, review_quorum, subject_hash, and institutional_policy_ref are completely unexplained, including the allowed values for 'action'.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description names the resource (dual-use research review) and lists scope elements (evidence, reviewers, decisions, escalation), which hints at what the tool organizes. But the verb 'Organise' is vague about whether this creates, updates, or adjudicates a review, and nothing distinguishes it from close siblings like v1_bio_risk_assess, v1_decision_attest, or v1_compliance_check.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no indication of when to call this versus the many sibling bio/compliance/decision tools, nor any prerequisites or ordering constraints. The only context offered is the paid route and price, which tells an agent nothing about selection criteria.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.